Sec Form 4 Filing - Deese Willie A @ Merck & Co. Inc. - 2014-06-27

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Deese Willie A 2. Issuer Name and Ticker or Trading Symbol Merck & Co. Inc. [ MRK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Exe V-P & Pres. MMD (Last) (First) (Middle) ONE MERCK DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 06/27/2014 (Street) WHITEHOUSE STATION, NJ08889-0100 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 06/27/2014 M 42,956 A $ 23.45 149,178.3873 D Common Stock 06/27/2014 M 22,108 A $ 35.09 171,286.3873 D Common Stock 06/27/2014 M 7,226 A $ 31.84 178,512.3873 D Common Stock 06/27/2014 S( 1 ) 72,290 D $ 58.255( 2 ) 106,222.3873( 3 ) D Common Stock - 401(k) Plan 679.9051( 4 ) I By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy) $ 31.84 06/27/2014 M 7,226 02/25/2006 02/24/2015 Common Stock 7,226 $ 0 0 D Stock Option (right to buy) $ 35.09 06/27/2014 M 22,108 03/03/2007 03/02/2016 Common Stock 22,108 $ 0 0 D Stock Option (right to buy) $ 23.45 06/27/2014 M 42,956 04/24/2010 04/23/2019 Common Stock 42,956 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Deese Willie A ONE MERCK DRIVE WHITEHOUSE STATION, NJ08889-0100 Exe V-P & Pres. MMD Signatures Katie Fedosz as Attorney-in-Fact for Willie A. Deese 06/30/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. ( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.9600 to $58.5200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. ( 3 )Holdings include shares acquired in dividend reinvestment transactions. ( 4 )Includes shares acquired and dividends earned through April 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.